drugset

drugset / Trial / NCT00618748

Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

NCT00618748 ↗

Phase 3 Completed 101 enrolled Eli Lilly and Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of olanzapine in the long-term treatment for patients with bipolar I disorder, depressed.

Timeline

Start: 2008-02
Primary completion: 2010-09
Completion: 2010-09

Publications

Katagiri H, Tohen M, McDonnell DP, Fujikoshi S, Case M, Kanba S, Takahashi M, Gomez JC. Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis. Psychiatry Clin Neurosci. 2014 Jul;68(7):498-505. doi: 10.1111/pcn.12156. Epub 2014 Mar 4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Olanzapine	Small molecule	—	Oral

Indications